SCHEMBL402300

SCHEMBL402300

O=C(c1ccccc1)c1ccc(OCc2ccccc2)cc1

nearest known ligand 0.87

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRD5A2 P31213 2/20 0.87
SMN1; SMN2 Q16637 3/20 0.79
ALDH1A1 P00352 2/20 0.79
HTT P42858 2/20 0.79
L3MBTL1 Q9Y468 1/20 0.79
NR4A2 P43354 2/20 0.77
NR4A1 P22736 1/20 0.77
NR4A3 Q92570 1/20 0.77
RAB9A P51151 2/20 0.74
GAA P10253 2/20 0.74
MAPT P10636 1/20 0.74
MAOB P27338 1/20 0.72
PARP10 Q53GL7 1/20 0.72
PPARG P37231 2/20 0.68
PLA2G4B P0C869 1/20 0.66
NPC1 O15118 1/20 0.64
LMNA P02545 1/20 0.63
CYP1A2 P05177 1/20 0.63
PTGS1 P23219 1/20 0.63
SLC6A2 P23975 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3232949 0.98 SRD5A2 (0.90) SRD5A2SMN1; SMN2ALDH1A1HTTL3MBTL1
SCHEMBL3415530 0.93 SRD5A2 (0.81) SRD5A2SMN1; SMN2ALDH1A1HTTL3MBTL1
SCHEMBL6654887 0.90 SRD5A2 (0.77) SRD5A2SMN1; SMN2ALDH1A1HTTL3MBTL1
SCHEMBL10784972 0.90 SRD5A2 (0.77) SRD5A2SMN1; SMN2ALDH1A1HTTL3MBTL1
SCHEMBL8067849 0.90 SRD5A2 (0.77) SRD5A2SMN1; SMN2ALDH1A1HTTL3MBTL1
SCHEMBL8503299 0.90 SRD5A2 (0.77) SRD5A2SMN1; SMN2ALDH1A1HTTL3MBTL1
SCHEMBL8503301 0.89 NR4A2 (0.74) SRD5A2SMN1; SMN2ALDH1A1HTTL3MBTL1
SCHEMBL6238323 0.89 ALDH1A1 (0.73) SRD5A2SMN1; SMN2ALDH1A1HTTL3MBTL1
SCHEMBL31556120 0.89 ALDH1A1 (0.78) SRD5A2SMN1; SMN2ALDH1A1HTTL3MBTL1
SCHEMBL27704685 0.89 RXRA (0.74) SRD5A2SMN1; SMN2ALDH1A1HTTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 246 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115698786-B Laminated film, polarizing plate and liquid crystal display device 柯尼卡美能达株式会社 2026-05-15 CN disclosed
CN-121586857-A Optical laminate 住友化学株式会社 2026-02-27 CN disclosed
CN-114846377-B Optical laminate and image display device 住友化学株式会社 2024-12-03 CN disclosed
CN-114846374-B Optical laminate and image display device 住友化学株式会社 2024-11-01 CN disclosed
US-12024632-B2 Near infrared absorbing composition, near infrared cut filter, solid state image sensor, and camera module Konica Minolta, Inc. (JP) 2024-07-02 US disclosed
US-11971563-B2 Near-infrared absorbing composition, near-infrared absorbing film, and image sensor for solid-state imaging element Konica Minolta, Inc. (JP) 2024-04-30 US disclosed
CN-117047953-A Method for producing optical film, polarizing plate, and liquid crystal display device 柯尼卡美能达株式会社 2023-11-14 CN disclosed
US-20230340269-A1 NEAR-INFRARED ABSORBING COMPOSITION, NEAR-INFRARED ABSORBING FILM, NEARINFRARED ABSORBING FILTER AND IMAGE SENSOR FOR SOLID-STATE IMAGING ELEMENTS Konica Minolta, Inc. (JP) 2023-10-26 US disclosed
US-11753547-B2 Near-infrared absorbing composition, near-infrared absorbing film, and image sensor for solid-state imaging element Konica Minolta, Inc. (JP) 2023-09-12 US disclosed
CN-114096632-B Adhesive sheet, laminate, display device, and organic electroluminescent display device 富士胶片株式会社 2023-06-27 CN disclosed
US-5698567-A LIPOXYGENASE INHIBITOR ADIR ET COMPAGNIE (FR) 1997-12-16 US disclosed
CN-1136568-A New heterocyclic spiro compounds, process for preparation thereof, and pharmaceutical compositions containing them ADIR (FR) 1996-11-27 CN disclosed
EP-0743312-A1 Spiroheterocyclic compounds, process for their preparation and pharmaceutical compositions containing them ADIR ET COMPAGNIE (FR) 1996-11-20 EP disclosed
EP-0683774-A1 HYPOLIPIDAEMIC COMPOUNDS THE WELLCOME FOUNDATION LIMITED (GB) 1995-11-29 EP disclosed
US-4996225-A Antitumor agents FARMOS GROUP LTD. (FI) 1991-02-26 US disclosed
EP-0172961-B1 1-BUTENE POLYMER AND ITS USE MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1988-10-19 EP disclosed
EP-0131358-B1 FIRE-RETARDANT 1-BUTENE RESIN COMPOSITION MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1988-08-17 EP disclosed
US-4696949-A ANTITUMOR AGENTS, ANTIESTROGENS FARMOS GROUP LTD. (FI) 1987-09-29 US disclosed
EP-0095875-B1 NOVEL TRI-PHENYL ALKANE AND ALKENE DERIVATIVES AND THEIR PREPARATION AND USE Farmos Group Ltd. (FI) 1986-09-10 EP disclosed
EP-0095875-A2 Novel tri-phenyl alkane and alkene derivatives and their preparation and use Farmos Group Ltd. (FI) 1983-12-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11971563-B2 Near-infrared absorbing composition, near-infrared absorbing film, and image sensor for solid-state imaging element IK, CA1, CA9 SRD5A2 3499/4885SMN1; SMN2 2435/4885ALDH1A1 3205/4885
US-20230340269-A1 NEAR-INFRARED ABSORBING COMPOSITION, NEAR-INFRARED ABSORBING FILM, NEARINFRARED ABSORBING FILTER AND IMAGE SENSOR FOR SOLID-STATE IMAGING ELEMENTS STRA6, SPR, IK SRD5A2 2296/4885SMN1; SMN2 1795/4885ALDH1A1 2187/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.